In addition, we investigated whether the ratio of hsa-miR-182 with targeted RNAs (THBS1 and CHL1) and the ratio of hsa-miR-183 with targeted RNAs (CCNB1) have an impact on the prognosis of patients with HCC. This evidence concerns the gene CHL1 and hepatocellular carcinoma.